TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP)

CUSIP: 890260201

Q3 2014 13F Holders as of 30 Sep 2014

Share change
+140,450
Put/Call ratio
146%
SEC-reported price per share
$6.85
Number of holders
25
Value change
+$140,775
Number of buys
17
Open additional details 1 more signal available
Number of sells
7

Security key

890260201

Report period

Q3 2014

Institutions

25

Top holders

0

Ownership snapshot

Top reported holders of TNXP - TONIX PHARMACEUTICALS HLDG C - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Archived quarter

Historical 13F summary for Q3 2014

This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.

There are no holders of TNXP - TONIX PHARMACEUTICALS HLDG C - COM NEW as of Q3 2014.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .